SpringWorks Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

SpringWorks Therapeutics

02/08/2023 12:32

* SpringWorks Therapeutics Inc  SWTX.OQ  reported a
quarterly
adjusted loss of $1.25​​ per share for the quarter ended in
June. The mean expectation of six analysts for the quarter was
for a loss of $1.26 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * SpringWorks Therapeutics Inc's reported EPS for the
quarter was
a loss of $1.25​.
    * The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * SpringWorks Therapeutics Inc shares had risen by 13.8%
this
quarter and gained 14.8% so far this year.
    * The company reported a quarterly loss of $77.93 million.
    * Wall Street's median 12-month price target for SpringWorks
Therapeutics Inc is $45.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 2 at 11:31 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.26          -1.25          Beat
 Mar. 31 2023      -1.25          -1.18          Beat
 Dec. 31 2022      -1.22          -1.17          Beat
 Sep. 30 2022      -1.32          -1.37          Missed